Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.55% | 1.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.55% | 1.77% | |||
| Cost of Revenue | -3.07% | 2.09% | |||
| Gross Profit | 2.88% | 1.33% | |||
| SG&A Expenses | -3.23% | 2.20% | |||
| Depreciation & Amortization | -2.61% | -4.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.12% | 2.07% | |||
| Operating Income | 30.24% | -1.77% | |||
| Income Before Tax | 574.33% | -166.33% | |||
| Income Tax Expenses | 367.08% | -49.56% | |||
| Earnings from Continuing Operations | 342.25% | -254.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -115.75% | 1,194.21% | |||
| Net Income | 399.36% | -220.52% | |||
| EBIT | 30.24% | -1.77% | |||
| EBITDA | 26.55% | -1.78% | |||
| EPS Basic | 398.97% | -220.51% | |||
| Normalized Basic EPS | 6.80% | 18.32% | |||
| EPS Diluted | 394.92% | -222.33% | |||
| Normalized Diluted EPS | 5.43% | 19.73% | |||
| Average Basic Shares Outstanding | 0.13% | 0.02% | |||
| Average Diluted Shares Outstanding | 1.43% | -1.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||